Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells.
about
Adoptive T-Cell ImmunotherapyRituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation.T cells for viral infections after allogeneic hematopoietic stem cell transplantII. Challenges in the management of post-transplant lymphoproliferative disorder.The exciting "bench to bedside" journey of cell therapies for acute kidney injury and renal transplantation.Immunotherapy against cancer-related viruses.Epstein-Barr Virus-Positive Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation: Pathogenesis, Clinical Manifestations, Diagnosis, and Management.Potent immunotherapy against well-established thymoma using adoptively transferred transgene IL-6-engineered dendritic cell-stimulated CD8+ T-cells with prolonged survival and enhanced cytotoxicity.Current Trends and Alternative Scenarios in EBV Research.Immunotherapy for transplantation-associated viral infections.Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients.Adoptive T cell therapy for the treatment of viral infections.Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies.A retrospective analysis of post-transplant lymphoproliferative disorder following liver transplantation.
P2860
Q26782845-2311F049-B5D7-4DC1-B450-88F21CA38C4EQ37012569-6D70A233-24BD-46D3-8FDE-CB4D162FFF33Q37058107-8AE5BB57-E869-4322-B833-A4D84F44A09EQ38524036-E3B2EA46-FAE2-4AB0-9179-0067A1B52F71Q38558079-C1AE2D89-A160-43F0-8BDD-F3888BFE5519Q38778924-E764DBA3-73DC-4305-9F54-42A90766B986Q38833567-0D8E2DB8-220A-438E-B386-4DAAE3D9FEE9Q38849071-72C888C1-0F9B-4536-968E-25689C5F2117Q39016336-4EE8C605-7E15-4010-AB62-34F95CF678CEQ39382670-80CAC266-69E8-4874-9DC1-C75B25037F3DQ40298660-D3296A6B-FB42-46F9-8B83-708D12D060CBQ40895824-A14E6977-B411-4E0D-BCB0-56CDCA4A1BF6Q47409813-9FC87283-0B2A-4A29-B2C0-9E72527E1957Q47671688-0C1FC7C8-70A4-480B-A82A-BCE843B2C835
P2860
Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Towards gene therapy for EBV-a ...... BV-specific cytotoxic T cells.
@ast
Towards gene therapy for EBV-a ...... BV-specific cytotoxic T cells.
@en
Towards gene therapy for EBV-a ...... BV-specific cytotoxic T cells.
@nl
type
label
Towards gene therapy for EBV-a ...... BV-specific cytotoxic T cells.
@ast
Towards gene therapy for EBV-a ...... BV-specific cytotoxic T cells.
@en
Towards gene therapy for EBV-a ...... BV-specific cytotoxic T cells.
@nl
prefLabel
Towards gene therapy for EBV-a ...... BV-specific cytotoxic T cells.
@ast
Towards gene therapy for EBV-a ...... BV-specific cytotoxic T cells.
@en
Towards gene therapy for EBV-a ...... BV-specific cytotoxic T cells.
@nl
P2093
P2860
P50
P1433
P1476
Towards gene therapy for EBV-a ...... BV-specific cytotoxic T cells.
@en
P2093
Adrian Thrasher
Jennifer Brewin
Persis J Amrolia
P2860
P304
P356
10.1182/BLOOD-2014-01-553362
P407
P577
2014-09-02T00:00:00Z